Cargando…

Expression of CD44 and the survival in glioma: a meta-analysis

Background: Higher tumor expression of CD44, a marker of cancer stem cells (CSCs), is associated with poor overall survival (OS) in various cancers. However, the association between CD44 and poor OS remains inconsistent in glioma. We aimed to evaluate the potential predictive role of CD44 for progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Gang, Song, Xinghui, Liu, Jun, Li, Shize, Gao, Weiqin, Qiu, Mingxing, Yang, Changjin, Ma, Yiming, Chen, Yuhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160241/ https://www.ncbi.nlm.nih.gov/pubmed/32232385 http://dx.doi.org/10.1042/BSR20200520

Ejemplares similares

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level
por: Klank, Rebecca L., et al.
Publicado: (2017)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity
por: Ramos, Erika K, et al.
Publicado: (2022)

CD44‐associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage
por: Liu, Wei‐Hsiu, et al.
Publicado: (2019)

CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022)

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)

ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
por: Kamarajan, Pachiyappan, et al.
Publicado: (2013)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells
por: Pal, Debjani, et al.
Publicado: (2017)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)
por: Dubey, Parul, et al.
Publicado: (2022)

CD44v9 is associated with epithelial‐mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma
por: Taniguchi, Daisuke, et al.
Publicado: (2018)

CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
por: Asai, Ryoma, et al.
Publicado: (2019)

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival
por: Näsman, Anders, et al.
Publicado: (2013)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

SALL4 ‐ KHDRBS3 network enhances stemness by modulating CD44 splicing in basal‐like breast cancer
por: Matsumoto, Yoshiaki, et al.
Publicado: (2018)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

GALNT2 sustains glioma stem cells by promoting CD44 expression
por: Liu, Yingying, et al.
Publicado: (2023)

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
por: Chen, Yujin, et al.
Publicado: (2018)

Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment
por: Weitzenböck, Hans Peter, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis
por: Qiao, Guang-Lei, et al.
Publicado: (2018)

LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
por: Li, Yabin, et al.
Publicado: (2021)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

CD44 (+) cells determine fenofibrate‐induced microevolution of drug‐resistance in prostate cancer cell populations
por: Wróbel, Tomasz, et al.
Publicado: (2020)

Identification of glioma-associated antigen MUC 2-63 as CD44.
por: Romeijn, P., et al.
Publicado: (1994)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis
por: Zhu, Xiaoyun, et al.
Publicado: (2020)

Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice
por: Lu, Zhaohui, et al.
Publicado: (2016)

Uridine phosphorylase 1 is a novel immune‐related target and predicts worse survival in brain glioma
por: Wang, Jin, et al.
Publicado: (2020)

Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
por: Liu, Jingjing, et al.
Publicado: (2019)

Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta‐analysis
por: Feng, Yuan, et al.
Publicado: (2019)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer
por: Lin, Neng-Yu, et al.
Publicado: (2023)

Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer
por: Gotoda, Takuji, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_mh95lt0cmkqpt97ahrmia54vht